Elopag 50mg Tablets

Product Description

Elopag 50mg Tablets contain Eltrombopag, an oral medication used to increase platelet counts in patients with specific blood disorders that cause thrombocytopenia (low platelet count). It is commonly prescribed under specialist supervision to help reduce the risk of bleeding and support platelet production in eligible patients.

Product Overview

Product Name: Elopag 50mg Tablets
Generic Name: Eltrombopag Olamine 50mg
Form: Tablets
Pack Size: 28 Tablets
Manufactured By: Everest Pharmaceuticals
Used For: Chronic Immune Thrombocytopenia (ITP), Hepatitis C-associated thrombocytopenia, and Severe Aplastic Anemia
Prescription Required: Yes

Ingredients & How They Work

The active ingredient in Elopag is Eltrombopag Olamine 50mg.

• Eltrombopag is a thrombopoietin receptor agonist that stimulates the bone marrow to produce more platelets.
• It helps increase platelet counts in patients suffering from conditions associated with low platelet levels.
• By improving platelet production, it may help reduce the risk of bleeding complications under medical supervision.

Key Benefits

Elopag 50mg Tablets are prescribed as part of a specialist treatment plan for patients with low platelet counts.

• Helps increase platelet production
• Supports management of chronic immune thrombocytopenia (ITP)
• Used in thrombocytopenia associated with chronic hepatitis C
• May be used in the treatment of severe aplastic anemia under specialist supervision
• Helps reduce the risk of bleeding related to low platelet counts

How to Use

Take Elopag exactly as prescribed by your healthcare provider. Dosage and treatment duration depend on the patient's condition, platelet count, liver function, and response to therapy. Regular blood tests are required to monitor platelet levels and treatment safety. Do not adjust the dose without medical advice.

Side Effects & Precautions

Possible side effects may include nausea, diarrhea, vomiting, headache, muscle pain, elevated liver enzymes, upper respiratory tract infections, or other adverse reactions. Patients should undergo regular monitoring of blood counts and liver function tests. Use only under the supervision of a qualified healthcare professional.

Who Should Use

Suitable for patients diagnosed with chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, or severe aplastic anemia when prescribed by a qualified physician. Treatment should be managed by a healthcare professional experienced in blood disorders.

Storage Instructions

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Use only according to the manufacturer's instructions and healthcare provider's recommendations.